CTRI/2015/02/005519招募中未知
Patterns of Relapse, Salvage Therapy and its Outcome in Locally Advanced Cervical Cancer treated with Radical Radio (Chemo)therapy - A retrospective analysis
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 650
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Patients with a histopathological diagnosis of carcinoma cervix .
- •2 Patients accrued in the IRB approved following trial - Trial No.461,281,158,253,844,601,114,205
- •3 Patients with documented relapse .
排除标准
- •1 Patients with relapse other then above mentioned IRB approved trial
研究者
相似试验
已完成
不适用
Differentiation between relapse and therapy-associated transformations in high-grade glioma by PET/MRTGlioma WHO-Grading II-IVC71Malignant neoplasm of brainDRKS00013453Radiologische Klinik, Universitätsklinikum Tübingen, Abt. Neuroradiologie119
尚未招募
3 期
Does Escitalopram helps in early recovery and prevent relapse in cases of idiopathic central serous retinopathy which causes blister like elevation at the centre of retina causing loss of visioCTRI/2011/11/002148DrGNageswar Rao110
已完成
不适用
Efficacy of relapse prevention techniques and social skills training for juveniles who have sexually offendedISRCTN38356086Child and Adolescent Psychiatric Service, Canton of Zurich (Switzerland)120
进行中（未招募）
1 期
A clinical study to provide the opportunity to be treated with CTL019, an investigational gene therapy, for children and adolescent patients with a recurrent form of B-cell acute lymphoblastic leukaemia after the closure of the Novartis single-arm phase II pivotal registration trial (Study CCTL019B2202) and to collect additional safety information.Paediatric/young adult patients with B-cell acute lymphoblastic leukaemia who are chemo-refractory, relapsed after allogeneic SCT, or are otherwise ineligible for allogeneic SCT.MedDRA version: 19.1 Level: LLT Classification code 10063625 Term: Acute lymphoblastic leukemia recurrent System Organ Class: 100000004864MedDRA version: 19.1 Level: LLT Classification code 10063621 Term: Acute lymphoblastic leukaemia recurrent System Organ Class: 100000004864EUCTR2016-001991-31-ESovartis Farmacéutica, S.A.55
进行中（未招募）
1 期
A clinical study to provide the opportunity to be treated with CTL019, an investigational gene therapy, for children and adolescent patients with a recurrent form of B-cell acute lymphoblastic leukaemia after the closure of the Novartis single-arm phase II pivotal registration trial (Study CCTL019B2202) and to collect additional safety information.Paediatric/young adult patients with B-cell acute lymphoblastic leukaemia who are chemo-refractory, relapsed after allogeneic SCT, or are otherwise ineligible for allogeneic SCT.MedDRA version: 20.0Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 100000012975MedDRA version: 20.0Level: LLTClassification code 10063621Term: Acute lymphoblastic leukaemia recurrentSystem Organ Class: 100000012975EUCTR2016-001991-31-FRovartis Pharma AG55